Why the study?
Does ambulatory blood pressure monitoring to detect non-dipping improve cardiovascular risk stratification in patients with diabetes?
Does ambulatory blood pressure monitoring to detect non-dipping improve cardiovascular risk stratification in patients with diabetes?
Answers are grounded in this paper and cite their sources.
Ambulatory blood pressure monitoring to detect non-dipping is a pivotal tool for improving cardiovascular risk stratification in diabetic patients.
A reduced fall in nocturnal blood pressure (BP) (i.e. non-dipping) has been related to an increase in target organ damage and cardiovascular (CV) events. Numerous studies have shown that non-dipping is highly prevalent in patients with type 1 and 2 diabetes mellitus. In this paper we reviewed recent literature and our personal data on the prevalence and clinical correlates of abnormal diurnal BP rhythm in diabetic patients; in particular we examined the association of this condition with renal, cardiac, and vascular pre-clinical organ damage as well as CV prognosis. A consistent body of evidence based on cross-sectional and longitudinal studies indicates that the lack of the physiologic nocturnal fall in BP may be considered a true clinical trait, a reliable marker of preclinical CV and renal disease and an independent predictor of future CV events. Thus, in the diabetic setting ambulatory BP monitoring (ABPM) should be regarded as a pivotal tool for improving CV risk stratification and therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Cuspidi et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: